We work with our clients to shape the healthcare system of tomorrow
The pressures on life sciences organisations today are not new in name, but they are new in intensity and pace. Evidence expectations from health technology assessment bodies are rising. Regulatory frameworks like EU HTA are reshaping how value is defined and rewarded. AI is changing both the clinical landscape and the way organisations need to operate. And the stakeholders that determine whether a therapy reaches patients, from policymakers to care providers, are more demanding and more fragmented than ever before. The companies gaining ground are the ones rethinking how they engage across all of these dimensions, not just one at a time.
Four propositions. One integrated practice.
Vintura works with life sciences companies across four interconnected areas. Each addresses a different dimension of the challenge: the policy environment that shapes access, the partnerships that improve how care is delivered, the commercial and medical strategies that determine how value is created, and the organisational foundations that make execution possible. They are designed to work together, because the challenges rarely arrive one at a time.
A different kind of partner
Most consultancies working in life sciences advise from the outside. They understand the industry, but they see it from one side of the table. Vintura works differently. Since 1999, we have built deep relationships across the full healthcare ecosystem, working not only with pharmaceutical and biotech companies, but with the payers, healthcare providers, and governments they depend on for access, adoption, and sustainable impact. That cross-system perspective is not incidental to our advice. It is the foundation of it.
We are a specialist firm. We work exclusively in healthcare and life sciences, which means every framework we bring, every insight we offer, and every challenge we help navigate has been shaped by years of work in this specific context, not adapted from another industry.
Who we work with
Vintura works with international pharmaceutical, biotech, and medical device companies, from global organisations managing complex multi-market launches to mid-size companies building their commercial and access capabilities for the first time. Our work typically engages leaders and teams in Commercial, Medical Affairs, Market Access, HEOR, and Policy, spanning strategy development, organisational design, and hands-on implementation, often all three at once.
We can help you with
Policy Shaping
“Across Europe, the gap between what medicine can offer and what patients actually receive remains wide, persistent, and largely preventable.”
Value-Based Partnerships
“Becoming a trusted partner in the healthcare system is a structural shift: from competing to collaborating, from supplying a product to co-owning an outcome.”
Organisational Transformation
“Strategy alone no longer determines if life science organizations win. How effectively your organizational structure enables you to execute it does.”
Commercial Strategies
“The commercial logic that drove the pharmaceutical industry for decades no longer holds. Clinical proof of concept gets you to the door. It no longer gets you in.”
8,8
Our average client satisfaction score, based on structured evaluations across all completed engagements. We are proud of it, and we work to deserve it on every project.
Poka is glad to tell you more about our impact in life sciences.
